Suvretta Capital Management, LLC Atai Life Sciences N.V. Transaction History

Suvretta Capital Management, LLC

  • $2.54 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$2.38 - $3.55 $981,652 - $1.46 Million
412,459 Added 33.66%
1,637,960 $4.36 Million
Q3 2022

Nov 14, 2022
BUY
$3.14 - $4.87 $36,339 - $56,360
11,573 Added 0.95%
1,225,501 $4.06 Million
Q2 2022

Aug 15, 2022
BUY
$3.03 - $5.32 $3.68 Million - $6.46 Million
1,213,928 New
1,213,928 $4.42 Million

Others Institutions Holding ATAI

# of Institutions
87
Shares Held
12.4M
Call Options Held
77.8K
Put Options Held
50.3K
View Full List

About ATAI Life Sciences N.V.

ATAI Quotes by TradingView
  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $197M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track Suvretta Capital Management, LLC Portfolio

Follow Suvretta Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email